Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
28.41
-0.60 (-2.07%)
Apr 23, 2026, 12:54 PM EDT - Market open
Hims & Hers Health Employees
Hims & Hers Health had 2,442 employees as of December 31, 2025. The number of employees increased by 805 or 49.18% compared to the previous year.
Employees
2,442
Change (1Y)
805
Growth (1Y)
49.18%
Revenue / Employee
$961,358
Profits / Employee
$52,566
Market Cap
6.48B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,442 | 805 | 49.18% |
| Dec 31, 2024 | 1,637 | 591 | 56.50% |
| Dec 31, 2023 | 1,046 | 395 | 60.68% |
| Dec 31, 2022 | 651 | 253 | 63.57% |
| Dec 31, 2021 | 398 | 217 | 119.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 778 |
| Prestige Consumer Healthcare | 600 |
HIMS News
- 1 day ago - Hims & Hers expands into menopause care as estrogen patch demand rises - Reuters
- 6 days ago - What's Going On With Hims & Hers Shares - Benzinga
- 6 days ago - RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC
- 7 days ago - Hims rises as FDA considers broader peptides access; analysts see long-term win - Reuters
- 7 days ago - Hims & Hers surges 4% as peptide policy shift unlocks growth - Invezz
- 7 days ago - Hims & Hers Health Stock Rallies on Regulatory Pivot. It's Not About GLP-1s This Time. - Barrons
- 7 days ago - Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides - Market Watch
- 9 days ago - Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026 - Business Wire